Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 2010 June;56(2) > Minerva Gastroenterologica e Dietologica 2010 June;56(2):213-31

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

A Journal on Gastroenterology, Nutrition and Dietetics


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEWS  CUTTING EDGE TOPICS IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY


Minerva Gastroenterologica e Dietologica 2010 June;56(2):213-31

language: English

An approach to the management of re-fractory ulcerative colitis

Sonu I. 1, Blonski W. 2,3, Lin M. V. 4, Lichtenstein G. R. 2

1 University of Pennsylvania, School of Medicine, Philadelphia, PA, USA;
2 Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA, USA;
3 Department of Gastroenterology, Medical University, Wroclaw, Poland;
4 Department of Internal Medicine, Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, PA, USA


PDF  


Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology associated with dysregulation of the gastrointestinal mucosal immune system. It is characterized by a waxing and waning course and approximately 15% of UC patients will experience a severe episode. The first line treatment for severe colitis includes IV corticosteroids, however, 40% of patients are non-responsive to corticosteroid therapy and may require either colectomy, intravenous infliximab or intravenous cyclosporine within 3-5 days of presentation. This review focuses on the management and treatment approaches to refractory UC.

top of page

Publication History

Cite this article as

Corresponding author e-mail

grl@uphs.upenn.edu